|
|
| WEDNESDAY, JULY
10, 2002 |
| POSTER SESSION:
CELLULAR CHOLESTEROL HOMEOSTASIS |
ISOLATION AND CHARACTERIZATION OF CDNAS ENCODING SCAVENGER
RECEPTOR CLASS B TYPE I AND II IN RABBIT
A. Ritsch, R. Gander, P. Eller, W.A. Schgor, B.
Foger, U. Stanzl, J.R. Patsch, Austria |
KINETIC STUDY OF HDL SELECTIVE CHOLESTERYL ESTER UPTAKE
IN DOGS USING STABLE ISOTOPES
E. Bailhache, K. Ouguerram, P. Nguyen, P. Maugere,
M. Krempf, T. Magot, France |
THE SCAVENGER RECEPTOR CLASS B, TYPE I COLOCALIZES WITH
CAVEOLAE AND PROMOTES PARTITIONING OF HDL ASSOCIATED ALPHA-TOCOPHEROL
INTO CAVEOLAE IN PORCINE BRAIN CAPILLARY ENDOTHELIAL CELLS
Z. Balazs, U. Panzenboeck, A. Sovic, W. Sattler,
Austria |
PRAVASTATIN UP REGULATES TGF-BETA1 IN THP-1 HUMAN MACROPHAGES:
EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION
G. Baccante, G. Mincione, M.C. Di Marcantonio,
A. Piccirelli, E. Porreca, Italy |
MARKED INDUCTION OF STEROL 27-HYDROXYLASE (CYP27) ACTIVITY
AND MRNA LEVELS DURING DIFFERENTIATION OF HUMAN CULTURED
MONOCYTES INTO MACROPHAGES
M.D. Hansson, E. Ellis, M.C. Hunt, G. Schmitz,
A. Babiker, Sweden, Germany |
HUMAN STEROL 27-HYDROXYLASE (CYP27) OVEREXPRESSOR TRANSGENIC
MOUSE MODEL. EVIDENCE AGAINST 27-HYDROXYCHOLESTEROL AS
A CRITICAL REGULATOR OF CHOLESTEROL HOMEOSTASIS
D.Kitsberg, I. Alkalay, F. Szafer, K. Meir, H.
Rosen,S. Shpizen, L. Ben Avi, B. Staels, C. Fievet,
V. Meiner, I. Bjorkhem, E. Leitersdorf, Israel, Sweden
|
INTERNALIZATION OF THE CLASS A SCAVENGER RECEPTOR IS REGULATED
BY CYTOPLASMIC DOMAIN
Q. Chen, X. Guan, China |
ENHANCED EXPRESSION OF LEUKOTACTIN (Lkn-1) MRNA AND PROTEIN
IN HUMAN THP-1 MONOCYTES-DERIVED FOAM CELLS AND IN ATHEROSCLEROTIC
LESION
R. Yu, C-S. Kim, T. Kawada, B-S. Kwon, South Korea,
Japan |
DIFFERENTIAL REGULATION OF ABCA1 EXPRESSION AND CHOLESTEROL
EFFLUX DURING ADIPOSE DIFFERENTIATION
S. Le Lay, X. Le Liepvre, P. Ferr?, I. Dugail,
France |
IN PERITONEAL MACROPHAGES OF OVARIECTOMIZED MICE THE EXPRESSION
OF THE HUMAN CETP GENE DIMINISHES THE UPTAKE OF 3H-CHOLESTERYL
OLEOYL ETHER ACETYLATED LDL AND, TOGETHER WITH ESTROGEN
TREATMENT, INCREASES THE 14C EFFLUX RATE FROM CELLS PRE-LOADED
WITH ACETYLATED 14C-CHOLESTERYL ESTER LDL
P.M. Cazita, L.M. Harada, L. Asakura, H.C.F. Oliveira,
E.C.R. Quintao, Brazil |
INCIDENCE OF ABCAI GENE DEFECT IN HYPOALPHALIPOPROTEINEMIC
COHORT IN THE NETHERLANDS
G.K. Hovingh, M. Van Wijland, M.R.H. Hayden, J.J.P.
Kastelein, A.K. Groen, Canada |
SEVER HYPOALPHALIPOPROTEINEMIA,
IMPARED CHOLESTEROL EFFLUX AND INCREASED SUSCEPTIBILITY
TO ATHEROSCLEROSIS IN APOA1/C3/A4 KNOCKOUT MICE
H. Mezdour, G. Castro, J. Fruchart, M. Rouis, G.
Torpier, N. Maeda, France, USA |
| POSTER SESSION:
GENETIC FACTORS |
LDL-RECEPTOR GENE MUTATIONS, BLOOD LIPID LEVELS AND CLINICAL
MANIFESTATIONS OF ATHEROSCLEROSIS IN PATIENTS WITH FAMILIAL
HYPERCHOLESTEROLEMIA AND IN THEIR CLOSE RELATIVES
V. Konstantinov, I. Liberman, A. Denisenko, V.
Larionova, E. Schwartz, Russia |
SCREENING ASP9-ASN POLYMORPHISM IN EXON 2 OF LIPOPROTEINLIPASE
GEN IN FAMILIAR COMBINED HYPERLIPIDEMIA (FCHL)
A. Hernandez-Mijares, M. Casado, M.L. Martinez-Triguero,
A. Lopez-Ruiz, E. Sola, S. Garzon,
A. Lopez-Gutierrez, C. Morillas, Spain |
MUTATION IN APOB ASSOCIATED WITH REDUCED PRODUCTION AND
CATABOLISM OF LDL AND A HYPOBETA PHENOTYPE. THE COPENHAGEN
CITY HEART STUDY
M.Benn, B.G. Nordestgaard, J. Skov Jensen, A. Tybjaerg-Hansen,
Denmark |
CD14 C(-260)>T GENE POLYMORPHISM IS NOT A RISK FACTOR
FOR MYOCARDIAL INFARCTION
M.T. Longombardo, A.B. Cefalu', G. Emmanuele, V.
Valenti, F. Pezzino, C.M. Buglino,
B. Fiore, C.M. Barbagallo, D. Noto, M.C. Mazzarino, M.
Rizzo, A. Notarbartolo, S. Travali,
M.R. Averna, Italy |
GENDER AND AGE SPECIFIC CONTRIBUTIONS OF ADDITIONAL DNA
SEQUENCE VARIATION IN THE 5'REGULATORY REGION OF THE APOE
GENE TO PREDICTION OF MEASURES OF LIPID METABOLISM
R.Frikke-Schmidt, C.F. Sing, B.G. Nordestgaard, A.
Tybjaerg-Hansen, Denmark, USA |
FIBRINOGEN POLYMORPHISMS AND CEREBROVASCULAR DISEASE
I.I. Correia, S. Viegas, P. Nogueira, M.T.F. De Seixas,
A.M.S.M Miranda, Portugal |
EARLY DIAGNOSIS OF CAROTID ATHEROSCLEROSIS IN FAMILIAL
HYPERCHOLESTEROLEMIA CAUSED BY PADUA-1 AND PADUA-4 MUTATIONS
B. Sabini, A. Calabro, S. Martini, G. Mazzetto,
L. Previato, I. Cortella, G. Maraglino, G. Frigo,
S. Bertolini, G. Crepaldi, Italy |
ATHEROSCLEROTIC CHANGES OF CAROTID ARTERIES: ANALYSIS
OF ASSOCIATION WITH CANDIDATE GENES POLYMORPHISM
A.N. Ryabikov, M.I. Voevoda, S.K. Malyutina, E.A.
Shakhtshneider, T.N. Kuznetsova,
A.G. Romaschenko, Russia |
REVERSE-HYBRIDIZATION ANALYSIS OF MULTIPLE GENETIC RISK
FACTORS FOR CARDIOVASCULAR DISEASE
A. Moritz, F. Kury, C. Oberkanins, Austria |
APO A-I PROMOTER POLYMORPHISM INFLUENCES BASAL HDL-CHOLESTEROL
AND ITS RESPONSE TO PRAVASTATIN THERAPY
R. Pena, C. Lahoz, J.M. Mostaza, J. Jimenez, E.
Subirats, X. Pinto, M. Taboada,
A. Lopez-Pastor, Spain |
APOE GENOTYPE AS A RISK FACTOR OF MYOCARDIAL INFARCTION
IN YOUNG PEOPLE
C. Garces, M. Benavente, E. Viturro, B. Cano,
J. Romero, E. Martin, J. Farre, M. De Oya, Spain |
A COMMON POLYMORPHISM OF MICROSOMAL TRIGLYCERIDE TRANSFER
PROTEIN POLYMORPHISM (-493 G/T) IS ASSOCIATED WITH INCREASED
SMALL CHYLOMICRON PARTICLES IN DIABETES
C. Phillips, M. Bell, D. Owens, P. Collins, G.
Tomkin, Ireland |
SELECTIVE SCREENING OF GENETIC DISLIPEMIAS IN ITALIAN
CHILDREN
C. Bondone, G. Mercadante, C. Allora, I. Rabbone,
O. Guardamagna, Italy |
LDL-RECEPTOR MUTATIONS IN NEW ZEALAND PATIENTS WITH FAMILIAL
HYPERCHOLESTEROLAEMIA
C.J. Lintott, C. Bunn, L. Henry, R.S. Scott, J.
Mann, P. George, New Zealand |
LDL-RECEPTOR GENE MUTATIONS AND CARDIOVASCULAR RISK IN
A LARGE POPULATION WITHOUT SELECTION FOR CARDIOVASCULAR
DISEASE
M.A.W.Umans-Eckenhausen, E.J.G. Sijbrands, J.J.P.
Kastelein, J.C. Defesche,
The Netherlands |
TWO NOVEL POLYMORPHISMS OF THE LDL-RECEPTOR GENE IN GREEK
PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
G. Dedoussis, C. Pitsavos, J. Skoumas, G. Sokari,
M. Prassa, C. Stefanadis, P. Toutouzas, Greece |
TANGIER DISEASE: A CASE REPORT
G.K. Hovingh, A. Van Tol, A.H.M. Smelt, M.R. Hayden,
J.J.P. Kastelein, J.A. Kuivenhoven,
The Netherlands, Canada |
PHENOTYPE AND GENOTYPE IN HOMOZYGOUS AND COMPOUND HETEROZYGOUS
FH PATIENTS
G. Reyes, S Castillo, P. Mozas, D. Tejedor, F.
Civeira, R. Alonso, P. Mata, F. Almagro,
M. Franco, J. Tebar, M. Pocovi, Spain |
PIG APOLIPOPROTEIN A-IV MRNA HEPATIC EXPRESSION IS COORDINATE
INSIDE THE A-I/C-III/A-IV GENE CLUSTER IN DIETARY RESPONSE
BUT NOT IN INFLAMMATION
M.A. Navarro, S. Acin, M. Iturralde, L. Calleja, R. Carnicer,
M.A. Guzman-Garcia,
N. Gonzalez-Ramon, P. Mata, B. Isabel, C.J. Lopez-Bote,
F. Lampreave, A. Pineiro, J. Osada,
Spain |
-455 G/A POLYMORPHISM OF THE BETA-FIBRINOGEN GENE IS ASSOCIATED
WITH INCREASED SYSTEMIC PROSTAGLANDIN E2: A POSSIBLE LINK
BETWEEN INFLAMMATION AND VASCULAR RISK
J.A. Paramo, J. Orbe, Y. Lopez, O. Beloqui, J.A. Rodriguez,
I. Monreal, J. Diez, Spain |
A POLYMORPHISM IN THE UPSTREAM REGION OF THE PKC BETA
GENE IS ASSOCIATED WITH MACROVASCULAR DISEASES IN JAPANESE
PATIENTS WITH TYPE 2 DIABETES
Y. Ikeda, T. Suehiro, F. Osaki, S. Tsuzura, Y.
Kumon, K. Hashimoto, Japan |
MOLECULAR GENETIC ANALYSIS FOR FAMILIAL PREDISPOSITION
TO HYPERCHOLESTEROLEMIA
K.B. Brusgaard, L.S. Krogh, H. Haar, P. Jordan,
A.G. Shou, K. Rasmussen, A.B. Hansen,
M. Hoeder, Denmark |
MOLECULAR BASIS OF FAMILIAL HYPERCHOLESTEROLEMIA IN BRAZIL:
IDENTIFICATION OF NINE NOVEL LDLR GENE MUTATIONS
L.A. Salazar, M.H. Hirata, S.A. Cavalli, E.R.
Nakandakare, N.A. Forti, J. Diament, S. Giannini,
M.C. Bertolami, R.D.C. Hirata, Brazil, Chile |
FAMILIAL DYSBETALIPOPROTEINAEMIA AND STRUCTURAL VARIANT
APOE2*(ARG136CYS)
M. Vrablik, A. Horinek, J. Sobra, R. Ceska, Czech
Republic |
PARENTAL ATTITUDE TOWARDS GENETIC TESTING FOR FAMILIAL
HYPERCHOLESTEROLEMIA IN CHILDREN
M.A.W. Umans-Eckenhausen, F.J. Oort, K.C.M.P. Ferenschild,
J.C. Defesche,
J.J.P. Kastelein, H.C.J.M. De Haes, The Netherlands |
IDENTIFICATION OF MOLECULAR DEFECTS IN PORTUGUESE PATIENTS
WITH FAMILIAL HYPERCHOLESTEROLAEMIA
M. Bourbon, Q. Rato, J.M. Silva, A. Guerra, P.M.
Silva, H.G. Santos, J. Lavinha, A.K. Soutar,
Portugal, UK |
MATERNAL AND NEONATAL LIPOPROTEIN CONCENTRATIONS ARE INVERSELY
INFLUENCED BY MATERNAL SST1 POLYMORPHISM OF APOCIII
O.S. Descamps, M. Bruniau, P-F. Guilmot, F.R.
Heller, Belgium |
THE NEONATAL CHOLESTEROL CONCENTRATION IS REDUCED NOT
ONLY IN PRESENCE OF APOE2 ALLELE IN NEONATES BUT ALSO
IN PRESENCE OF APOE2 IN THEIR MOTHERS
O.S. Descamps, M. Bruniau, P-F. Uilmot, F.R. Heller,
Belgium |
A ROLE OF Sp1 IN REGULATION OF HUMAN SERUM PARAOXONASE
GENE TRANSCRIPTION
F. Osaki, Y. Ikeda, T. Suehiro, K. Ota, S. Tsuzura,
K. Arii, Y. Kumon, K. Hashimoto, Japan |
MAPPING OF QUANTITATIVE TRAIT LOCI INVOLVED IN ATHEROSCLEROSIS
IN THE MOUSE
R. Korstanje, R. Li, G. Churchill, B. Paigen,
USA |
DETECTION OF HETEROZYGOUS LIPOPROTEIN LIPASE (LPL) GENE
MUTATIONS BY ELECTROCHEMICAL HYBRIDIZATION ASSAY WITH
FERROCENYLNAPHTHALENE DIIMIDE
Y. Ikeda, A. Takagi, K. Yamashita, S. Takenaka,
T. Miyahara, M. Takagi, Japan |
THE K121Q POLYMORPHISM IN THE PLASMA CELL MEMBRANE GLYCOPROTEIN
1 (PC-1) GENE PREDISPOSES TO EARLY MYOCARDIAL INFARCTION
R. Sunder-Plassmann, G. Endler, H. Sunder-Plassmann,
M. Exner, M. Schillinger,
A. Klimesch, S. Kapiotis, S. Meier, F. Kunz, K. Huber,
C. Mannhalter, O. Wagner, Austria |
THE MOLECULAR BASIS OF FAMILIAL HYPERCHOLESTEROLEMIA IN
THE NETHERLANDS
S.W. Fouchier, M.A.W. Umans-Eckenhausen, J.J.P.
Kastelein, J.C. Defesche,
The Netherlands. |
HERITABILITY OF CHD-MORTALITY
S. Zdravkovic, A. Wienke, N.L. Pedersen, M.E.
Marenberg, A.I. Yashin, U. De Faire, Sweden, Germany,
USA |
HIGH PREVALENCE OF R3500Q CAUSING FDB IN THE NORTHWEST
OF SPAIN
S. Castillo, D. Tejedor, P. Mozas, G. Reyes, M.
Pueyo, R. Alonso, P. Mata, J.J. De La Cruz,
M. Pocovi, Spanish Group of FH, Spain |
|
GEOGRAPHICAL CLUSTERING OF LOW DENSITY LIPOPROTEIN RECEPTOR
GENE MUTATIONS (C2X;
Q363X; D365E & C660X) IN CYPRUS
S.L. Xenophontos, A. Pierides, K. Demetriou,
P. Avraamides, P. Manoli, N. Ayrton,
N. Skordis, V. Anastasiadou, G. Miltiadous, M.A. Cariolou,
Cyprus
|
SINGLE ALLELE DOUBLE MUTANTS IN HETEROZYGOUS FAMILIAL
HYPERCHOLESTEROLEMIA
S. Amsellem, D. Briffaut, O. Khallouf, J.P. Rabes,
J.P. Girardet, A. Fredenrich, P. Moulin,
Y. Reznik, B. Vialettes, J.L. De Gennes, E. Bruckert,
France |
THE B1B1 GENOTYPE OF THE CHOLESTERYL ESTER TRANSFER PROTEIN
TAQ1B POLYMORPHISM IS A NOVEL RISK FACTOR IN THE DEVELOPMENT
OF CORONARY ARTERY DISEASE IN KOREANS
K-W. Park, H-K. Kim, J-H. Choi, S. Oh, I-H. Chae,
H-S. Kim, B-H. Oh, M-M. Lee, Y-B. Park,
Korea |
MARBURG I POLYMORPHISM OF FACTOR VII ACTIVATING PROTEASE
(FSAP) - A PROMINENT RISK PREDICTOR OF ARTERIAL THROMBOSIS
J. Willeit, S. Kiechl, C.J. Wiedermann, T. Weimer,
J. Roemisch, Austria, Germany |
THE - 516 C ALLELE IN THE APOLIPOPROTEIN B100 PROMOTER
IS ASSOCIATED WITH LOW LIPID LEVELS AND WITH A LOW FREQUENCY
OF SUBCLINICAL ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC
PATIENTS
S. Gonbert, A. Sposito, G. Turpin, J. Chapman,
J. Thillet, France |
ASSOCIATIONS OF GENES LIPOPROTEIN LIPASE AND APOLIPOPROTEIN
E WITH MYOCARDIAL INFARCTION AND LONGEVITY
N.A. Malygina, Russia |
NOVEL TRUNCATING APOB GENE MUTATIONS (APOB-6.9 AND APOB-25.8)
CAUSING FAMILIAL HYPOBETALIPOPROTEINAEMIA
A.J. Hooper, C.E. Herbison, P.H.R. Barrett, F.M. Van Bockxmeer,
J.R. Burnett, Australia |
SIX LIPOPROTEIN LIPASE SNPS,
LEVELS OF TRIGLYCERIDE AND HDL, AND RISK OF ISCHEMIC HEART
DISEASE (IHD); THE COPENHAGEN HEART STUDY
H.H. Wittrup, R.V. Andersen, G. Jensen, R. Steffensen,
A. Tybjaerg-Hansen,
B.G. Nordestgaard, Denmark |
METABOLISM OF CHYLOMICRON-LIKE
EMULSIONS IN SUBJECT WITH SER 447-STOP LIPOPROTEIN LIPASE
POLYMORPHISM
R. Schreiber, C.M.C. Strunz, R.F. Amancio, J.S.
Issa, R.D. Santos, S. Bydlowsky,
R.C. Maranhao, Brazil |
| POSTER SESSION:
NON-INVASIVE AND INVASIVE TECHNIQUES |
PULSE WAVE ANALYSIS AND CARDIOVASCULAR EVENT RISK PREDICTION
IN PATIENTS WITH HYPERLIPIDEMIA
G.S. Toor, A.S. Wierzbicki, S. Millaseau, P.J.
Chowienczyk, J.M. Ritter, UK |
NON-INVASIVE DETECTION OF LOCAL CEREBRAL ISCHEMIA IN THE
HYPERLIPIDEMIC PATIENTS AND POSITIVE CEREBRAL HEMODYNAMICS
AFTER SIMVASTATIN TREATMENT
B.M. Lipovetsky, G.V. Kataeva, A.D. Korotkov,
Russia |
CENTRAL INTRACARDIAL AND CEREBRAL HEMODYNAMICS IN HYPERTENSIVE
AND NORMOTENSIVE STROKE PATIENTS
T. Romanjuk, S. Kuznetsova, Ukraine |
STRUCTURE OF CORRELATIONS BETWEEN CEREBRAL BLOOD FLOW
VALUES IN VARIOUS BRAIN AREAS IN ISCHEMIC STROKE PATIENTS
WITH ATHEROSCLEROSIS
V.V. Kuznetsov, Ukraine |
THE SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS) 11 USED IN
THE EVALUATION OF OUTCOME IN PATIENTS WITH ACUTE CORONARY
SYNDROME ADMITTED AT THE CORONARY CARE UNIT
C.E. Marinas, R.E. Ramboyong, R.T. Tibayan, C.S.
Oro, E.S. Caguioa, D.R. Flores Jr.,
Philippines |
ECHOTOMOGRAPHIC CAROTID B-MODE ULTRASOUND (ECBUS) IN ASSESSMENT
OF CAROTID ATHEROSCLEROSIS IN PATIENTS WITH CORONARY ARTERY
DISEASE (CAD)
E. Pedro, J. Baptista, I. Tareco, J. Ferreira,
S. Gomes, Portugal |
EVALUATION OF THE INTIMA-MEDIA THICKNESS IN FAMILIAL COMBINED
HYPERLIPEMIA PATIENTS
G. Mercadante, E. Rolfo, C. Bondone, C. Allora,
M. Bo, O. Guardamagna, Italy |
TREATMENT WITH ATORVASTATIN DECREASES THE PULSE WAVE VELOCITY
IN THE LOWER LIMB ARTERIES IN PATIENTS WITH TYPE 2 DIABETES
MELLITUS
K. Shinohara, T. Shoji, E. Kimoto, S. Fujiwara,
T. Maeno, M. Komatsu, H. Koyama, M. Emoto,
Y. Nishizawa, Japan |
B-MODE ULTRASOUND MEASUREMENTS OF ACHILLES TENDONS IN
PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA AND CONTROLS
L. Jakulj, M. Basart, M. Trip, D. Marais, J. Kastelein,
E. De Groot, The Netherlands,
South Africa |
PROGRESS WITH THE CALIBRATION OF A 3F NEAR INFRARED SPECTROSCOPY
FIBER OPTIC CATHETER FOR MONITORING THE PLAQUE PH TO DETECT
VULNERABLE PLAQUE
T. Khan, B. Soller, M. Madjid, S.W. Casscells, J.T. Willerson,
M. Naghavi, USA |
A NOVEL INTRAVASCULAR QUARTER-WAVE LENGTH RESONATOR FOR
J.Wosik , K. Nesteruk, L.M. Xie, J.A. Bankson,
J.D. Hazle, M. Kamel, J.T. Willerson,
M. Naghavi, USA, Poland |
PLAQUE-TARGETED MRI CONTRAST MEDIA; INTRODUCING A NOVEL
SPIO CONTRAST MEDIA FOR MR IMAGING OF MACROPHAGE INFILTRATION
IN VULNERABLE PLAQUE
M. Azadpour, D. Chan, M. Madjid, C. Jagannath, S.W. Casscells,
J.T. Willerson, M. Naghavi,
USA |
ANGIOSCOPIC OBSERVATION OF THE ATHEROSCLEROSIS OF CHOLESTEROL-FED
OVARIECTOMISED JAPANESE MONKEYS
R. Torii, N. Ikeda, T. Ito, S. Yamada, M. Shiomi,
Y. Eguchi, Japan |
COMPARISON OF CENTRAL PULSE PRESSURE AND AUGMENTATION
INDEX DERIVED FROM ANALYSES OF CAROTID AND RADIAL ARTERY
WAVEFORMS
R.J. Woodman, G.F. Watts, B.A. Kingwell, L.J.
Beilin, S.E. Hamilton, A.M. Dart, Australia |
FOREARM HYPEREMIA IS A BETTER MARKER THAN CAROTID ULTRASOUND
OR ANKLE-BRACHIAL INDEX FOR JAPANESE CORONARY PATIENTS
S. Tonari, H. Nishimura, K. Fukunishi, T. Mori,
Y. Kitaura, Japan |
RELATIONS BETWEEN CARTOID
PLAQUES, INTIMA MEDIA THICKNESS AND MORBIDITY IN ELDERLY
MEN WITH LONGSTANDING HYPERCHOLESTEROLEMIA
E.M. Hjerkinn, L. Bergengen, I. Seljeflot, I. Hjermann,
H. Arnesen, Norway |
TECHNICAL COMPARISON OF METHODS FOR MEASURING ARTERIAL
COMPLIANCE
R.J. Woodman, G.F. Watts, B.A. Kingwell, L.J.
Beilin, S.E. Hamilton, A.M. Dart, Australia |
| POSTER SESSION:
LIPASES, LCAT, CETP, PLTP - SESSION I |
ASSOCIATION AMONG CETP TAQIB GENE POLYMORPHISM, HDL-C
LEVEL, AND ISCHEMIC HEART DISEASE IN A POPULATION-BASED
SAMPLE: THE SHIGARAKI STUDY
Y. Tsujita, Q. Zhang, S. Tamaki, Y. Nakamura,
Y. Kita, T. Okamura, A. Nozaki, H. Ueshima,
Japan |
DECREASED PLTP MASS, WITH INCREASED SPECIFIC ACTIVITY,
IN HYPERTRIGLYCERIDEMIC PATIENTS WITH INSULIN RESISTANCE
A. Van Tol, I.J.A.M. Jonkers, H. Hattori, L.M.
Scheek, A.H.M. Smelt, The Netherlands, Japan |
CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) CONCENTRATION
INFLUENCES PROGRESSION OF ATHEROSCLEROSIS AND RESPONSE
TO PRAVASTATIN TREATMENT; THE REGRESS STUDY
A.H.E.M. Klerkx, G.J. De Grooth, A.H. Zwinderman,
J.W. Jukema, J.A. Kuivenhoven,
J.J.P. Kastelein, The Netherlands |
ALTERNATIVE PATHWAY OF FREE FATTY ACID UPTAKE FROM PHOSPHOLIPIDS
AND UPREGULATION OF DE NOVO FATTY ACID SYNTHESIS IN LIPOPROTEIN
LIPASE-DEFICIENT MURINE ADIPOSE TISSUE
D. Kratky, E.M. Wagner, R. Zimmermann, J.G. Strauss,
G. Haemmerle, E. Steyrer,
R. Zechner, Austria |
HYPERINSULINEMIA AND HYPERGLYCEMIA DOWNREGULATE LIPOPROTEIN
LIPASE ACTIVITY
J. Kovar, V. Fejfarova, T. Pelikanova, R. Poledne,
Czech Republic |
THE MATCHMAKER GAL4 TWO-HYBRID SYSTEM REVEALED BIOMOLECULAR
INTERACTION BETWEEN THE ELONGATION FACTOR EEF1A AND THE
ENZYME LIPOPROTEIN LIPASE IN HUMAN HEART
K. Preiss-Landl, M. Riederer, A. Rueck, R. Zechner,
Germany |
ELEVATED CETP ACTIVITY AND ENHANCED CELLULAR CHOLESTEROL
EFFLUX ARE KEY FEATURES OF POSTPRANDIAL LIPID METABOLISM
IN TYPE IIB HYPERLIPIDEMIA
M. Guerin, P. Egger, C. Soudant, W. Le Goff, A.
Van Tol, R. Dupuis, M.J. Chapman,
The Netherlands, France |
REDUCTION OF POSTPRANDIAL ACCUMULATION AND CETP-MEDIATED
REMODELLING OF TRIGLYCERIDE-RICH LIPOPROTEIN SUBSPECIES
BY ATORVASTATIN IN TYPE IIB HYPERLIPIDEMIA
M. Guerin, P. Egger, W. Le Goff, C. Soudant, R.
Dupuis, M.J. Chapman, France |
PROPEPTIDE MUTATIONS OF LYSOSOMAL ACID LIPASE
O. Zschenker, D. Özden, D. Ameis, Germany
|
EFFECT OF Taq IB CETP GENE POLYMORPHISM ON CHOLESTERYL
ESTER TRANSFER ACTIVITY AND LIPID PARAMETERS IN A TUNISIAN
TYPE 2 DIABETIC POPULATION
N. Attia, O. Mandhouj, K. Ben Hamda, A-S. Masmoudi,
R. Chaaba, M. Smaoui, S. Hammami,
P. Moulin, A. Girard-Globa, M. Hammami, Tunisia, France
|
REDUCTION OF LIPID AND CETP PLASMA CONCENTRATIONS BY DIETARY
PLANT STEROL ESTER TREATMENT IN MODERATE HYPERCHOLESTEROLEMIA
DOES NOT RELATE TO THE TAQ1B CETP POLYMORPHISM
A.M.Lottenberg , V.S. Nunes, E.R. Nakandakare,
M. Neves, M. Bernik, L. Lagrost, J.E. Santos,
E.C.R. Quintao, France, Brazil |
| POSTER SESSION:
NUCLEAR RECEPTORS |
PPAR GAMMA, LEPTIN AND ENDOTHELIAL CELL MEDIATED ANGIOGENESIS
A. Polus, E. Piatkowska, A. Dembinska-Kiec, Poland
|
THE PPARgamma AGONISTS AND THE JAGGED/NOTCH EXPRESSION
IN DIFFERENTIATING TO ENDOTHELIUM PROGENITOR CD 34+ AND
HUVEC CELLS
A. Dembinska-Kiec, A. Polus, J. Grzybowska, Poland
|
PARAOXONASE-1 GENE EXPRESSION: THE IMPORTANCE OF THE T(-107)C
PROMOTER POLYMORPHISM, AND A ROLE FOR TRANSCRIPTION FACTORS
SP1 AND SREBP.
I. Leviev, S.P. Deakin, M-C. Brulhart, R.W. James,
Switzerland |
RIBOZYME-MEDIATED GENE TARGETING OF TRANSCRIPTIONAL COACTIVATORS,
CREB BINDING PROTEIN (CBP) AND P300 REVEALED THEIR INDISPENSABLE
ROLES IN ADIPOCYTE DIFFERENTIATION THROUGH THE REGULATION
OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA
T. Kawada, N. Takahashi, T. Yamamoto, T. Goto,
A. Taimatsu, N. Aoki, H. Kawasaki, K. Taira,
K.K. Yokoyama, Y. Kamei, T. Fushiki, Japan |
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA CONTROLS
MACROPHAGE CHOLESTEROL HOMEOSTASIS BY REDUCING CHOLESTEROL
ESTERIFICATION
G. Chinetti, S. Lestavel, J-C. Fruchart, V. Clavey,
B. Staels, France |
BETA-CATENIN AS A TRANSCRIPTIONAL REGULATOR OF THE SMOOTH
MUSCLE-MYOSIN HEAVY CHAIN GENE EXPRESSION
S. Sena, J. Lavie, M.M. Faraldo, J.M. Daniel Lamazière,
J. Bonnet, France |
TOLL-LIKE RECEPTOR 4 POLYMORPHISMS AND ATHEROGENESIS IN
HUMANS
S. Kiechl, E. Lorenz, M. Reindl, C.J. Wiedermann,
J. Willeit, D. Schwartz, USA, Austria |
INTRON RETINOIC X RECEPTOR
ALPHA POLYMORPHISM IN CHRONIC HEART FAILURE
M Goldbergova, L. Spinarova, J. Spinar, J. Toman,
A. Vascu, Czech Republic |
| POSTER SESSION:
NUTRITION |
PALATABILITY AND ACCEPTABILITY OF A LOW DOSE SOY PROTEIN/BETA-SITOSTEROL
ASSOCIATION AS CHOLESTEROL LOWERING AGENT
A.F.G. Cicero, M.P. Panourgia, A. Fiorito, S.
D'Addato, A. Gaddi, Italy |
6-MONTHS FOLLOW-UP OF 105 WOMEN TREATED WITH SOY ISOFLAVONES
BECAUSE OF A CLIMACTERIC SYNDROME
O. Iommelli , A.F.G. Cicero, G. Tommasillo,
Italy |
TISSUE INCORPORATION OF PLANT STEROLS AND STANOLS IN APOE3*
LEIDEN MICE
A. De Jong, J. Plat, O.L. Volger, H.M.G. Princen,
L.M. Havekes, R.P. Mensink,
The Netherlands |
EFFECTS OF DIFFERENT RATIOS OF PALMITIC AND LINOLEIC ACIDS
IN THE DIET ON PALMITIC ACID OXIDATION
E. Naumann, Y.C. Luiking, J. Plat, D.A.J.M. Kerckhoffs,
R.P. Mensink, The Netherlands |
ADDING PLANT STANOLS TO PLANT STEROLS DOES NOT PREVENT
AN INCREASE IN SERUM PLANT STEROL CONCENTRATIONS
E. Naumann, J. Plat, R.P. Mensink, The Netherlands
|
A
COMPARISON OF THE LDL-LOWERING EFFICACY OF PLANT STEROL
AND STANOL ESTERS
F.H. O'Neill, A.E. Brynes, R. Mandeno, M. Seed,
G.R. Thompson, UK |
ANTIATHEROSCLEROTIC AND ANTIATHEROGENIC EFFECTS OF GARLIC
EXTRACT PRINCIPALS
I.A. Sobenin, D.Y. Zalepugin, N.A. Til'kunova,
A.N. Orekhov, Russia |
ESTERIFIED PLANT STANOL IN LOW-FAT FOODS
P.M. Salo, Finland |
IMPACT OF INFANCY-ONSET DIETARY INTERVENTION AIMED AT
FAT MODIFICATION ON VITAMIN AND MINERAL INTAKE IN 5- TO
10-YEAR OLD CHILDREN, A PROSPECTIVE RANDOMISED TRIAL
S. Talvia, H. Lagström, T. Rönnemaa,
J. Viikari, O. Simell, Finland |
THE EFFECT OF A SINGLE SQUALENE-FAT MEAL ON SERUM NONCHOLESTEROL
STEROLS IN WOMEN WITH AND WITHOUT CORONARY ARTERY DISEASE
R.A. Rajaratnam, H. Gylling, T.A. Miettinen, Finland
|
NUTRITIONAL REGULATION OF LIPOPROTEIN LIPASE IN HUMANS
T. Ruge, M. Svensson, J.W. Eriksson, G. Olivecrona,
Sweden |
FOOD CONSUMPTION IN POLAND IN 1989-2000 AND CARDIOVASCULAR
MORTALITY
W. Sekula, W.B. Szostak, K. Figurska, Poland |
THE INFLUENCE OF THE COMBINATION OF MEDITERRANEAN DIET
AND STATIN TREATMENT ON THE RISK OF DEVELOPING ACUTE CORONARY
SYNDROMES; THE CARDIO2000 STUDY
D. Panagiotakos, C. Chrysohoou, C. Pitsavos, J.
Skoumas, M. Toutouza, I. Papaioannou,
K. Tzioumis, N. Marinakis, G. Koutsimbanis, P. Zambaras,
P. Zavitsanakis, D. Antoniades,
C. Stefanadis, P. Toutouzas, Greece |
THE DOUBLE BOND CONTENT IN BLOOD SERUM LIPOPROTEINS. STABILITY
OF THE DOUBLE BONDS/CHOLESTEROL RATIO
V.N. Titov, D.M. Lisitsin, Russia |
METHODS OF PHYSICAL CHEMISTRY IN THE EVALUATION OF THE
SEPARATE RECEPTOR-MEDIATED CELLULAR INTAKE OF SATURATED
AND ESSENTIAL POLYENIC FATTY ACIDS
D.M. Lisitsyn, V.N. Titov, V.A. Amelyushkina, V.V.
Kukharchuk, Russia |
BLOCKADE OF THE RECEPTOR-MEDIATED CELLULAR INTAKE OF ESSENTIAL
POLYENIC FATTY ACIDS AS THE BASIC FACTOR IN THE PATHOGENESIS
OF ATHEROSCLEROSIS
V.V. Kukharchuk, V.N. Titov, Russia |
EFFECT OF A HIGH PROTEIN, ENERGY RESTRICTED DIET ON BODY
COMPOSITION, INSULIN SENSITIVITY AND LIPID LEVELS IN HYPERINSULINEMIC
SUBJECTS
N.D. Luscombe, M. Noakes, G. Wittert, E. Farnsworth, E.
Argyiou, P.M. Clifton, Australia |
EFFICACY AND METABOLIC EFFECTS OF TWO DIETS FOR TREATING
OBESITY
F. Muzio, E. Dalla Valle, C. Nalini, A. Torri, D. Sommariva,
A. Branchi, Italy |
SUPPLEMENTATION OF A-LINOLENIC OR LINOLEIC ACIDS DOES
NOT IMPROVE PLASMA LIPID LEVELS WHEN THE BACKGROUND DIET
IS A MEDITERRANEAN-TYPE
G. Paschos, I. Davies, B.A. Griffin, E. Theriu,
G. Anastasiadis, A. Zampelas, Greece, UK |
VALIDATION OF A SHORT FOOD
QUESTIONNAIRE FOR ASSESSMENT OF DIETARY HABITS
A.B. Svilaas, E.C. Strom, T. Svilaas, M. Thoresen, A.
Borgejordet, L. Ose, Norway |
| POSTER SESSION:
OXIDATIVE STRESS, ANTIOXIDANTS - SESSION II |
ERYTHROCYTES AND PLASMA MALONYL DIALDEHYDE (MDA) CONCENTRATION
DURING ATORVASTATIN AND FLUVASTATIN TREATMENT USED IN
CORONARY HEART DISEASE PRIMARY PREVENTION
J. Kowalski, J. Blaszczyki, L. Pawlicki, J. Grycewicz,
P. Kaczmarek, E. Rapacka, Poland |
INCREASED LEVELS OF LOW-DENSITY LIPOPROTEIN OXIDATION
IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA AND IN
END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS
L.J.H. Van Tits, J. De Graaf, H. Hak-Lemmers,
S.J.H. Bredie, P.N.M. Demacker,
P. Holvoet, A.F.H. Stalenhoef, The Netherlands, Belgium
|
EFFECT OF STATIN ON TRANSCRIPTION OF HUMAN SERUM PARAOXONASE
1 GENE
K. Ota, T. Suehiro, K. Arii, Y. Ikeda, Y. Kumon,
K. Hashimoto, Japan |
MYELOPEROXIDASE OXIDISED-LDL DELAY FIBRIN CLOT LYSIS ON
THE SURFACE OF ENDOTHELIAL CELLS
K. Zouaoui Boudjeltia, N. Moguilevsky, P. Delree,
M. Alvarez, J. Ducobu, P. Cauchie,
M. Guillaume, M. Vanhaeverbeek, D. Brohee, C. Remacle,
Belgium |
SERUM PARAOXONASE ACTIVITY CHANGES IN PATIENTS AFTER CORONARY
ARTERY BYPASS GRAFTING
L. Illyes, I. Seres, P. Fulop, G. Paragh, Hungary
|
CHANGE OF LIPIDPEROXIDATION AFTER RENAL TRANSPLANTATION
L. Locsey, I. Seres, A. Dan, L. Asztalos, G. Paragh,
Hungary |
ANTIOXIDANTS: VITAMIN E AND VITAMIN A IN HOSPITALIZED
ELDERLY WITH ATHEROSCLEROTIC DISEASE
M.E. Marquez, C.E. Yepez, R. Sutil De Naranjo,
L. Solano, M.F. Rincon, Venezuela |
RELATIONSHIP BETWEEN TOTAL ANTIOXIDANT STATUS AND BLOOD
LIPIDS IN HEALTHY WOMEN
M. Andonovska, Republic of Macedonia |
KINETICS OF HDL OXIDATION IN VITRO AND PARAOXONASE-1 AND
PARAOXONASE-1 POLYMORPHISMS IN FCHL FAMILY MEMBERS
M-L. Liu, R.W. James, K. Ylitalo, M-R. Taskinen,
Switzerland |
CARRIERS OF THE EPSILON3EPSILON2 APOE GENOTYPE DISPLAY
LESS SUSCEPTIBILITY TO IN VITRO OXIDATION OF LDL
M. De Oya, R. Rubio, H. Ortega, M. Benavente,
E. Viturro, B. Cano, D. Gomez-Coronado,
M.A. Lasuncion, C. Garces, Spain |
OXIDATIVE
MODIFICATION OF LDL AND HDL LIPOPROTEINS IN PATIENTS WITH
FAMILIAL LCAT DEFICIENCY
B. Idzior-Walus, J. Hartwich, W. Rostworowski,
T. Wesolowska, A. Dembienska-Kiec, J. Sieradzki, Poland |
POLYPHENOLIC FRACTION OF SILYMARIN POSITIVELY AFFECTS
LIPOPROTEIN PROFILE AND BLOOD GLUTATHIONE IN RATS FED
ON HIGH CHOLESTEROL HIGH FAT DIETS
N. Skottova, P. Vana, D. Walterova, R. Vecera,
K. Urbanek, Z. Chmela, J. Ulrichova,
V. Simanek, Czech Republic |
CIRCULATING LEVELS OF OXIDIZED LDL IN TYPE 2 DIABETIC
PATIENTS
P.P. Lindstedt, H.M. Bates, E. Lindgren, E. Hedlof,
Sweden |
STUDY ON THE INFLUENCE OF OXIDATIVE STRESS ON THE REMODELLING
AND HOMEOSTASIS OF ADIPOSE TISSUE: EFFECTS OF OXIDISED
LDL ON MURINE PREADIPOCYTE 3T3.L1 DIFFERENTIATION
R. Vari, R. Masella, M. D'Archivio, B. Scazzocchio,
F. Maialetti, G. Leto, C. Giovannini, Italy |
OXIDATIVE STRESS STATUS IN ADULTS WITH DIABETES MELLITUS
S.A. Dzhekova-Stojkova, M.A. Krstevska, G.L. Bosilkova,
Z.G. Stojkova, Macedonia |
EFFECT OF ATORVASTATIN ON AUTOANTIBODIES AGAINST OXIDIZED
LOW-DENSITY LIPOPROTEIN IN POSTMENOPAUSAL WOMEN WITH CORONARY
HEART DISEASE
V.S. Gurevich, S.A. Urazgildeeva, L.V. Shatilina,
M.M. Mnuskina, L.V. Oganesyan,
I.N. Makarova, Russia |
OXIDIZED PHOSPHOLIPIDS INHIBIT ACTION OF ENDOTOXIN IN
VITRO AND IN VIVO
V. Bochkov, A. Kadl, J. Huber, F. Gruber, B.R.
Binder, N. Leitinger, Austria |
EFFECT OF MECHANICAL STRESS ON MYOCARDIAL ANTI-OXIDANT
ENZYMES AND ISCHEMIC PRECONDITIONING IN RABBIT HEART
A. Grover, R. Vijayvergiya, A. Bahl, D. Sharma,
V.K. Bhargava, S. Majumdar, India |
| POSTER SESSION:
DRUGS |
EFFECTS OF FENOFIBRATE ON HDL PARTICLE SIZE IN PATIENTS
WITH HYPERTRIGLYCERIDEMIA - A DOUBLE-BLIND, CROSSOVER,
CONTROLLED STUDY
J. Sasaki, K. Yamamoto, M. Ageta, Japan |
DISTRIBUTION OF THERAPEUTIC PROCEDURES AND USE OF DRUG
THERAPIES IN PATIENTS WITH ANGIOGRAPHICALLY CONFIRMED
CORONARY ARTERY DISEASE IN TURKISH PATIENTS
(SINGLE CENTRE EXPERIENCE)
K. Sonmez, A. Akcay, M. Akcakoyun, D. Demir, O.H.
Elonu, O. Onat, N.E. Duran, M. Gencbay,
M. Degertekin, F. Turan, Turkey |
EZETIMIBE EFFECTIVELY REDUCES SERUM PLANT STEROLS IN PATIENTS
WITH SITOSTEROLEMIA
K. von Bergmann, G. Salen, D. Lutjohann, T. Musliner,
B. Musser, Germany, USA |
PREVENTION OF LDL MODIFICATION BY TRECRESAN
M.M. Korda, Ukraine |
FORMATION AND INCORPORATION OF GENISTEIN DERIVATIVES IN
HUMAN PLASMA LIPOPROTEINS
M.H. Kaamanen, H. Adlercreutz, M. Jauhiainen,
M.J. Tikkanen, Finland |
THE IMPROVEMENT OF ENDOTHELIAL FUNCTION AFTER QUINAPRIL
AND L-ARGININE THERAPY
M. Malczewska-Malec, M. Rajzer, A. Zdzienicka,
K. Kawecka-Jaszcz, A. Dembinska-Kiec,
Poland |
ELEVATION EFFECTS OF FENOFIBRATE UPON HDL-CHOLESTEROL
N. Nakaya, Y. Goto, Japan |
ACHIEVEMENT OF LDL CHOLESTEROL GOAL WITH ADDITION OF PLANT
STANOL ESTERS TO DIETS OF CORONARY HEART DISEASE (CHD
PATIENTS ON STATIN THERAPY
N.B. Cater, G.L. Vega, S.M. Grundy, USA |
EVALUATION OF DOSE RESPONSIVENESS TO PLANT STANOL ESTERS
N.B. Cater, G.L. Vega, S.M. Grundy, USA |
ACHIEVEMENT OF THE JOINT EUROPEAN SOCIETIES LDL-CHOLESTEROL
GOAL BY HYPERCHOLESTEROLAEMIC PATIENTS RECEIVING ROSUVASTATIN,
PRAVASTATIN OR SIMVASTATIN
R. Paoletti, L. Pisciotta, H. Southworth, I. Carbarns,
Italy, UK |
ROSUVASTATIN ENHANCES LIPID FLUIDITY IN ATHEROGENIC APO-B
CONTAINING LIPOPROTEINS
R. Prassl, M.J. Caslake, C.J. Packard, M.K. Palmer,
J.M. Chapman, P.N. Durrington,
P. Laggner, Austria, UK, France |
EFFECTS OF CAPTOPRIL UPON THE METABOLISM OF CHYLOMICRONS
R.J. Alves, R.F. Amancio, J. Diament, R.D. Santos, N.
Forti, J.A.F. Ramires, R.C. Maranhao,
Brazil |
MORE
WESTERN HYPERCHOLESTEROLEMIC PATIENTS ACHIEVE JAPANESE
ATHEROSCLEROSIS SOCIETY LDL-C TARGETS WITH ROSUVASTATIN
THERAPY THAN WITH PRAVASTATIN OR SIMVASTATIN THERAPY
K. Strutt, A. Dane, J. Blasetto, UK, USA |
INFLUENCE OF LDL RECEPTOR GENE POLYMORPHISMS ON SERUM
LIPID LEVELS AND RESPONSE TO ATORVASTATIN IN SUBJECTS
WITH FAMILIAL AND NON FAMILIAL HYPERCHOLESTEROLEMIA
L.A. Salazar, M.H. Hirata, S.A. Cavalli, E.R. Nakandakare,
N.A. Forti, J. Diament, S. Giannini,
M.C. Bertolami, R.D.C. Hirata, Brazil, Chile |
PHYTOSTEROLS IN COMMERCIAL CORN OIL REDUCE CHOLESTEROL
ABSORPTION
R.E. Ostlund, S.B. Racette, A. Okeke, W.F. Stenson,
USA |
RATIONALE, DESIGN, AND BASELINE CHARACTERISTICS OF A CLINICAL
TRIAL EVALUATING SAFETY AND EFFICACY OF SIMVASTATIN IN
CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA
S. De Jongh, A.F.H. Stalenhoef, M.B. Tuohy, M.
Mercuri, H.D. Bakker, J.J.P. Kastelein,
The Netherlands, USA |
MORE WESTERN HYPERCHOLESTEROLEMIC PATIENTS ACHIEVE JAPANESE
ATHEROSCLEROSIS SOCIETY LDL-C TARGETS WITH ROSUVASTATIN
THERAPY THAN WITH ATORVASTATIN THERAPY
K. Strutt, R. Caplan, H. Hutchinson, UK, USA |
FEMORAL INTIMA MEDIA THICKNESS IN PATIENTS WITH FAMILIAL
HYPERCHOLESTEROLEMIA TREATED WITH EITHER ATORVASTATIN
80MG OR SIMVASTATIN 40MG
S. van Wissen, T.J. Smilde, A.F.H. Stalenhoef,
J.J.P. Kastelein, The Netherlands |
REACHING LIPID TARGETS FOLLOWING STARTING DOSES OF STATINS
IN PRIMARY CARE: THE RESULTS OF THE CHECK-UP STUDY
S.A. Grover, I. Lowensteyn, M. Kaouache, S. Marchand,
L. Coupal, C. Brewer, Canada |
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING
STUDY OF ROSUVASTATIN IN JAPANESE HYPERCHOLESTEROLEMIC
SUBJECTS
Y. Saito, Y. Goto, A. Dane, K. Strutt, Japan,
UK |
ESTROGEN REPLACEMENT THERAPY LOWERS PLASMA LEVELS OF ASYMMETRIC
DIMETHYLARGININE, AN ENDOGENOUS INHIBITOR OF NITRIC OXIDE
SYNTHASE
T. Teerlink, S.J.M. Neele, S. De Jong, J.C. Netelenbos,
C.D.A. Stehouwer, The Netherlands |
DYSLIPIDEMIA ASSOCIATED WITH HIGHLY ACTIVE ANTIRETROVIRAL
THERAPY (HAART) FOR HIV INFECTION: ESTIMATING THE IMPACT
OF NELFINAVIR AND ATAZANAVIR ON CARDIOVASCULAR (CVD) RISK
AND MORTALITY
S.A. Grover, C. Brewer, N. Gilmore, J. Mukherjee,
M. Giordano, Canada, USA |
INHIBITION OF INTESTINAL CHOLESTEROL ABSORPTION BY EZETIMIBE
IN HUMANS
T. Sudhop, D. Lutjohann, A. Kodal, D. Tribble,
S. Shah, I. Perevozskaya, K. von Bergmann,
Germany, USA |
VALSARTAN IMPROVES FIBRINOLYTIC BALANCE IN ATHEROSCLEROTIC
RABBITS
M. Poubina, N. De Las Heras, S. Vazquez-Perez, E. Cediel,
D. Sanz-Rosa, V. Cachofeiro,
V. Lahera, Spain |
THE SYNERGIC EFFECT OF ATORVASTATIN AND QUINAPRIL IN ATHEROSCLEROTIC
RABBITS
N.De Las Heras , M.P. Oubina, S. Vazquez-Perez,
E. Cediel, D. Sanz-Rosa, C. Diez,
G. Hernandez, V. Lahera, V. Cachofeiro, Spain |
ANTI-ATHEROGENIC EFFECTS OF ANTI-INFLAMMATORY DRUG IN
THE HYPERCHOLESTEROLEMIC RABBIT
S. Asgary, G.H. Naderi, F. Kafil, A. Sajjadian,
S.H. Azali, Iran |
ANTIOXIDANT ACTION OF COMBINED THERAPY WITH TRIMETAZIDIN
AND AMINOACIDS IN ISCHEMIC HEART DISEASE OLD PATIENTS
R. Zaslavskaya, G. Dilmagambetova, E. Kalinina,
L. Goncharov, G. Lilitza, Russia |
DIET AND METFORMIN IN THE TREATMENT OF THE ABDOMINAL OBESE
PATIENTS
F. Dzgoeva, Russia |
EFFECTS OF THIAZOLIDINEDIONES ON PROLIFERATION AND PROTEOGLYCAN
BIOSYNTHESIS IN HUMAN VASCULAR SMOOTH MUSCLE CELLS
S.T. De Dios, G.L.R. Jennings, P.J. Little, Australia
|
PRIMARY AND SECONDARY PREVENTION
IN HYPERLIPIDAEMIC PATIENTS. THEIR COMPLIANCE WITH DIRECTIONS
AND TREATMENT GIVEN ACCORDING TO THE RECORDS OF OUR CLINIC
OF HYPERLIPIDAEMIAS
D.K. Theodoridis, A.D. Labrou, A.G. Savvopoulou,
L.F. Borghi, O.E. Koutsogiannis,
A.N. Zagoutis, S.K. Terzi, A.E. Panagiotidou, A.K. Gotsis,
Greece |
| POSTER SESSION:
RISK FACTORS, ATHEROSCLEROSIS AND MI |
EXPERIMENTAL HYPERLIPIDEMIA AND THE EFFECT OF NSAIDS
A. Kourounakis, P. Victoratos, N. Peroulis, N.
Stefanou, M. Yiangou, L. Hadjipetrou,
P.N. Kourounakis, Greece |
CARDIOVASCULAR DISEASE RISK FACTORS IN POST MENOPAUSAL
WOMEN IN WEST ANATOLIA: A RURAL REGION PREVALENCE STUDY
C. Sekuri, E. Eser, G. Akpinar, H. Cakir, I. Sitti,
O. Gulomur, C. Ozcan, Turkey |
PATIENT MODELS OF CORONARY HEART DISEASE
G. Krstacic, A. Krstacic, M. Jembrek-Gostovic,
Croatia |
RUPTURED PLAQUES, ULCERS AND THICKENED INTIMA: THAT'S
HOW MAN LOOKS INSIDE
I. Asmussen, Norway |
CUTTING BALLOON ANGIOPLASTY FOR AORTO-OSTIAL LESIONS
H. Nassar, M. Mosseri, M.S. Gotsman, C. Lotan,
Israel |
ACHIEVEMENT OF THE JOINT EUROPEAN SOCIETIES LDL-CHOLESTEROL
GOAL BY HYPERCHOLESTEROLAEMIC PATIENTS RECEIVING ROSUVASTATIN
OR ATORVASTATIN
H. Istad, L. Ose, S. Stender, H. Southworth, J.
Pears, Norway, UK |
DIFFERENTIAL PROFILES OF EARLY VERSUS LATER ONSET PERIPHERAL
ARTERIAL OCCLUSIVE DISEASE
S.N. Barretto, I.J. Kullo, USA |
THE EPSILON 2 ALLELE OF APOLIPOPROTEIN E PROTECTS FROM
ISCHEMIC VASCULAR EVENTS IN GREEK POPULATION
G. Kolovou, J. Malakos, D. Daskalova, N. Pilatis,
N. Yannakouris, M. Elisaf, E. Bilianou,
M. Cariolou, D.V. Cokkinos, Greece |
HIGH DENSITY LIPOPROTEIN CHOLESTEROL AND MYOCARDIAL INFARCTION
EXTENT
M. Fonda, A.M. Semolic, A. Pagnin, L. Vitali-Serdoz,
P. Gori, G. Sinagra, L. Cattin, Italy |
SERUM KINETICS OF THE BIOCHEMICAL MARKERS FOR ACUTE MYOCARDIAL
INFARCTION
M.M. Bogdanova, S.R. Domazetovsks, V.P. Arsova,
Macedonia |
CHANGES IN LEVELS OF TRIGLYCERIDE-RICH LIPOPROTEIN SUBFRACTIONS
DURING DIALYSIS IN UREMIC PATIENTS
M. Rizzo, C.M. Barbagallo, A. Pace, D. Noto, A.B.
Cefalu', A. Lo Cascio, C. Giammarresi,
A. Galione, M. Li Vecchi, A. Notarbartolo, M.R. Averna,
Italy |
ALL ATHEROSCLEROTIC PATIENTS ARE EQUAL, BUT SOME MORE
EQUAL THAN OTHERS. THE 'AIRVAG' COHORT. 3. RISK FACTOR
CONTROL AND TREATMENT
N. Mesa, I. Gonzalez-Anglada, M.L. Casas, L. Lopez-Bescos,
C. Sanchez, E. Puras, C. Martin,
M.L. Edista, M.A. Trevino, J. Jimenez, S. Lujan, F. Barriga,
R. Barba, H. Martin, C. Guijarro,
Spain |
HAS THE TIME TO CHANGE THE DEFINITION AND TREATMENT OF
ATHEROSCLEROSIS OCCURRED?
A. Svetlikov, A. Barsukov, L. Gaikovaya, Russia
|
ASSOCIATION BETWEEN APOLIPOPROTEIN E GENOTYPE AND CARDIOVASCULAR
DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS
P. Mozas, S. Castillo, G. Reyes, D. Tejedor, F.
Civeira, I. Garcia-Alvarez, J. Puzo, A. Cenarro,
R. Alonso, M. Pocovi, P. Mata, Spanish Group of Fh, Spain
|
THE ASSOCIATION OF PREVALENT CORONARY HEART DISEASE WITH
SEROLOGICALLY DIAGNOSED PERIODONTITIS
P.J. Pussinen, P. Jousilahti, G. Alfthan, S. Asikainen,
V. Salomaa, Finland |
RISK FACTORS OF NEGATIVE STRESS TEST AND ANGIOGRAPHICALLY
INSIGNIFICANT CORONARY ARTERY ATHEROSCLEROSIS
S-H. Chan, J-H. Chen, Taiwan |
IMPLEMENTATION OF GUIDELINES TO SCREEN RELATIVES OF PATIENTS
WITH PREMATURE CHD
S. Tonstad, A. Westheim, Norway |
LDL AND HDL SUBCLASS DISTRIBUTION IN PATIENTS WITH END-STAGE
RENAL DISEASES
S.B. Alabakovska, B.B. Todorova, D.D. Labudovic,
K.N. Tosheska, Macedonia |
CAN DISCUSSING A PATIENT'S CALCULATED CORONARY RISK INCREASE
THE EFFECTIVENESS OF DYSLIPIDEMIA THERAPY? PRELIMINARY
RESULTS OF THE CHECK-UP STUDY
S.A. Grover, I. Lowensteyn, L. Coupal, S. Marchand,
M. Kaouache, C. Brewer, Canada |
THE LIPID PROFILE OF PATIENTS
WITH LATTER HAEMORRHAGE FROM THE UPPER GASTROINTESTINAL
TRACT
S. Paximadas, S. Pagoni, A. Efstratopoulos, N.
Sakarelou, E. Liatzoura, A. Chantzis, Greece |
ANALYSIS AND STUDY OF SUDDEN CARDIAC DEATHS DUE TO ATHEROSCLEROSIS,IN
THE COUNTY OF TRIKALA, GREECE
T. Galeas, I. Hatzizisis, H. Zisis, S. Mylonas,
A. Papadopoulos, Greece |
THE LIPID LOWERING EFFECT OF YOGURT IN PATIENTS WITH HIGH
TOTAL CHOLESTEROL LEVEL
T.H. Chao, J.H. Chen, M-T. Lin, W.C. Tsai, Y.H.
Li, P.Y. Liu, Taiwan |
THE RELATIONSHIP BETWEEN CAROTID ARTERY DISEASE SEVERITY
AND STROKE PREVALANCE IN PATIENTS UNDERGOING CORONARY
ARTERY BYPASS SURGERY
S. Aytekin, Z. Ozyedek, V. Aytekin, E. Kabatas,
E. Rizaoglu, B. Akpinar, O. Yildirimturk,
R. Ozcan, I.C.C. Demiroglu, C.E.M.I. Demiroglu, Turkey
|
LIPID STUDY LEIPZIG (LSL): EVALUATION OF CARDIOVASCULAR
RISK FACTOR PROFILE ON POPULATION BASIS
V. Richter, F. Rassoul, K. Purschwitz, E. Richter,
M. Michel, S. Riedel, G. Schreinicke,
R. Schwarz, F. Jucker, K. Wenzel, J. Thiery, Germany |
THE TIME COURSE OF CORONARY HEART DISEASE AFTER REVASCULARISATION
PROCEDURES
V. Konstantinov, V. Gloukhov, Russia |
CLASSICAL RISK FACTORS AND THEIR IMPACT ON ACUTE MYOCARDIAL
INFARCTION IN ISRAEL. SUB-ANALYSIS OF THE ACSIS 2000 STUDY
A. Elis, M. Lishner, Israel |
THE DISTRIBUTIONS OF BLOOD LIPIDS, LIPOPROTEIN LP(A),
C-REACTIVE PROTEIN, HOMOCYSTEINE, FIBRINOGEN, APOLIPOPROTEINS
A-I AND B, BY SEX: THE ATTICA STUDY
C. Chrysohoou, D. Panagiotakos, C. Pitsavos, J.
Skoumas, M. Toutouza, I. Papaioannou,
A. Zeimbekis, C. Stefanadis, P. Toutouzas, Greece |
PSYCHOSOCIAL RISK FACTORS AND ACUTE CORONARY SYNDROMES:
THEIR IMPORTANCE BY GENDER; THE CARDIO2000 STUDY
D. Panagiotakos, C. Chrysohoou, C. Pitsavos, J.
Skoumas, I. Papaioannou, K. Tzioumis,
N. Marinakis, G. Koutsimbanis, P. Zambaras, P. Zavitsanakis,
D. Antoniades, C. Stefanadis,
P. Toutouzas, Greece |
EDUCATIONAL DIFFERENCES AND THE RISK OF DEVELOPING ACUTE
CORONARY SYNDROMES;
THE CARDIO2000 STUDY
D. Panagiotakos, C. Chrysohoou, C. Pitsavos, J.
Skoumas, I. Papaioannou, K. Tzioumis,
N. Marinakis, G. Koutsimbanis, P. Zambaras, P. Zavitsanakis,
D. Antoniades, C. Stefanadis,
P. Toutouzas, Greece |
EFFECT OF ESTROGENS AND PHYTOSOYA ADMINISTRATION ON VASCULAR
REACTIVITY IN HYPERCHOLESTEROLEMIC RABBITS
C. Castillo, V. Salazar, A. Holguin, S. Gonzalez,
V. Cachofeiro, C. Ariznavarreta,
J.A.F. Tresguerres, Spain |
DIFFERENCES IN LIPOPROTEIN PHENOTYPE IN FAMILIAL HYPERCHOLESTEROLEMIA
J.T. Real, F.J. Chaves, C. Gonzalez, F.J. Sanz, M.A. Priego,
J.F. Ascaso, M.E. Armengod,
R. Carmena, Spain |
APOLIPOPROTEIN B-100 / APOLIPOPROTEIN A-I RATIO IS THE
MOST USEFUL INDICATOR FOR CORONARY ARTERY DISEASE IN KOREANS
H-K. Kim, K-W. Park, E-K. Choi, D-H. Kim, S. Oh,
I-H. Chae, H-S. Kim, C-H. Kim, D-W. Sohn, B-H. Oh,
M-M. Lee, Y-B. Park, Y-S. Choi, Korea |
APOLIPOPROTEIN E GENOTYPE AND THE RESPONSE OF BLOOD LIPIDS
AND BLOOD INFLAMMATORY INDICES TO A-LINOLENIC ACID IN
HYPERLIPIDAEMIC SUBJECTS
G. Paschos, N. Yiannakouris, L. Rallidis, G. Liakos,
A. Zampelas, Greece |
PLASMA LEVELS OF SOLUBILE ADHESION MOLECULES SICAM-1 IN
ATHEROSCLEROSIS
A-M. Simundic, N. Vrkic, E. Topic, A. Begonja,
V. Nikolic-Heitzler, N. Zarkovic, Croatia |
CARDIOVASCULAR PREVENTION IN THE GENERAL PRACTICE (1):
DETECTION OF BARRIERS
R. De Muylder, V. Lorant, C. Prevost, F. Nackers, M. Jeanjean,
B. Boland, Belgium |
CARDIOVASCULAR PREVENTION IN THE GENERAL PRACTICE (2):
A CLINICAL ALGORITHM
B. Boland, R. De Muylder, D. Paulus, Y. Gueuning,
P. Legat, M. Jeanjean, Belgium |
CARDIOVASCULAR PREVENTION
IN THE GENERAL PRACTICE (3): A CLINICAL ALGORITHM
R. De Muylder, F. Nackers, D. Pestiaux, R. Tonglet, M.
Jeanjean, B. Boland, Belgium |
EMBOLIC OCCLUSION OF THE MIDDLE AND INTERNAL CAROTIDE
ARTERY. TREATMENT IN EMERGENT WITH RT-PA THROMBOLYTIC
AGENT
A. Limuris, B. Avlides, N. Fistas, Ch. Eftimiades,
Greece |
AORTO-BIFEMORAL GRAFT INFECTION THREE YEARS AFTER OPERATION
A. Limuris, N. Fistas, B. Avlides, Ch. Eftimiades,
Greece |
THE SURGERY OF DIGESTIVE ARTERIES
A. Limuris, N. Fistas, B. Avlides, Ch. Eftimiades,
Greece |
ALL ATHEROSCLEROTIC PATIENTS
ARE EQUAL, BUT SOME MORE EQUAL THAN OTHERS. THE 'AIRVAG'
COHORT.1. RISK FACTOR ASSESSMENT
N. Mesa, L. Lopez-Bescos, F. Barriga, P. Enrique,
M.L. Casas, J. Jimenez, C. Sanchez,
S. Lujan, I. Gonzalez-Anglada, J. Bilbao, G. Garcia-Casasola,
A. Rabano, A. Zapatero,
C. Guijarro, Spain |
ALL ATHEROSCLEROTIC PATIENTS
ARE EQUAL, BUT SOME MORE EQUAL THAN OTHERS. THE 'AIRVAG'
COHORT.2. RISK FACTOR ASSESSMENT
N. Mesa, C. Guijarro, S. Lujan, P. Enrique, M.L.
Casas, J. Jimenez, C. Sanchez, F. Barriga,
R. Tolon, M.A. Trevino, A. Espinosa, J.E. Losa, L. Lopez-Bescos,
Spain |
|
| | |
